Allometric principles for interspecies extrapolation in toxicological risk assessment--empirical investigations (Q46829244)

25 December 2017

title

Allometric principles for interspecies extrapolation in toxicological risk assessment--empirical investigations (English)

1 reference

25 December 2017

1 reference

Schneider K

1

1 reference

25 December 2017

Oltmanns J

series ordinal

2

1 reference

25 December 2017

Hassauer M

series ordinal

3

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

25 December 2017

Regulatory Toxicology and Pharmacology

published in

1 reference

25 December 2017

volume

39

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

334-347

1 reference

25 December 2017

Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Estimating noncancer uncertainty factors: are ratios NOAELs informative?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

1-Aminocyclopropanecarboxylic acid: mouse to man interspecies pharmacokinetic comparisons and allometric relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Biological basis for extrapolation across mammalian species.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

On reference dose (RfD) and its underlying toxicity data base

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

The use of dogs as second species in regulatory testing of pesticides. I. Interspecies comparison.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

The use of toxicokinetic and toxicodynamic data in risk assessment: an international perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Allometric scaling of xenobiotic clearance: uncertainty versus universality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Allometric issues in drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies scaling: predicting clearance of drugs in humans. Three different approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies scaling: predicting oral clearance in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Guidelines for application of chemical-specific adjustment factors in dose/concentration-response assessment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

The allometric approach for interspecies scaling of pharmacokinetic parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies extrapolation of pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Tissue dosimetry for reactive metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies Scaling of Anesthetic Potency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecific Scaling of Toxicity Data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Assessment factors for human health risk assessment: a discussion paper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Uncertainty factors for chemical risk assessment: interspecies differences in the in vivo pharmacokinetics and metabolism of human CYP1A2 substrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Uncertainty factors for chemical risk assessment: interspecies differences in glucuronidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies extrapolation: a reexamination of acute toxicity data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Animal pharmacokinetics and interspecies scaling of sordarin derivatives following intravenous administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies scaling of clearance and volume of distribution for horse antivenom F(ab')2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat, and mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Pharmacokinetics of halofantrine in the rat: stereoselectivity and interspecies comparisons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies pharmacokinetics of a novel hematoregulatory peptide (SK&F 107647) in rats, dogs, and oncologic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Allometric analysis of thiamphenicol disposition among seven mammalian species.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Unbound total (plasma) clearance approach in interspecies pharmacokinetics correlation: theophylline-cimetidine interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Mixed effect modeling of sumatriptan pharmacokinetics during drug development. I: Interspecies allometric scaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies scaling of tebufelone pharmacokinetic data and application to preclinical toxicology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies correlation of the pharmacokinetics of erythromycin, oleandomycin, and tylosin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Animal pharmacokinetics and interspecies scaling of FCE 22101, a penem antibiotic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Pharmacokinetics of the anticancer agent sulofenur in mice, rats, monkeys, and dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies scaling of cimetidine-theophylline pharmacokinetic interaction: interspecies scaling in pharmacokinetic interactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies scaling of clearance and volume of distribution for digoxin-specific Fab.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Comparative pharmacokinetics and interspecies scaling of amphotericin B in several mammalian species.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Pharmacokinetics of 2',3'-dideoxycytidine in rats: application to interspecies scale-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

The metabolism and kinetics of doxazosin in man, mouse, rat and dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies comparison of pharmacokinetics of the novel triazole antifungal agent SYN-2869 and its derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Dihydropyrimidine dehydrogenase inactivation and 5-fluorouracil pharmacokinetics: allometric scaling of animal data, pharmacokinetics and toxicodynamics of 5-fluorouracil in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies pharmacokinetic scaling of a new carbapenem, DA-1131, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Pharmacokinetics and tissue distribution of a new carbapenem DA-1131, after intravenous administration to mice, rats, rabbits and dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies pharmacokinetic scaling of metazosin, a novel alpha-adrenergic antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

A new extrapolation method from animals to man: application to a metabolized compound, mofarotene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies scaling of interferon disposition and comparison of allometric scaling with concentration-time transformations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies scaling of bosentan, a new endothelin receptor antagonist and integration of in vitro data into allometric scaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Animal pharmacokinetics and interspecies scaling from animals to man of lamifiban, a new platelet aggregation inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies pharmacokinetic comparisons and allometric scaling of napsagatran, a low molecular weight thrombin inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies pharmacokinetic scaling of some iodinated organic acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies pharmacokinetic scaling of BSH in mice, rats, rabbits, and humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Prediction of ACNU plasma concentration-time profiles in humans by animal scale-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies comparisons of plasma half-life of trimethoprim in relation to body mass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Comparative pharmacokinetics and interspecies scaling of 3'-azido-3'-deoxythymidine (AZT) in several mammalian species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Animal pharmacokinetics and interspecies scaling of Ro 25-6833 and related (lactamylvinyl)cephalosporins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Elucidation of human amphotericin B pharmacokinetics: identification of a new potential factor affecting interspecies pharmacokinetic scaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Prediction of the pharmacokinetic parameters of reduced-dolasetron in man using in vitro-in vivo and interspecies allometric scaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Pharmacokinetics of the inodilator XB513 in mice, rats, guinea pigs, rabbits, dogs, and monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Comparative pharmacokinetics of [14C]metosulam (N-[2,6-dichloro-3-methylphenyl]-5,7-dimethoxy-1,2,4- triazolo[1,5a]-pyrimidine-2-sulfonamide) in rats, mice and dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

Interspecies differences and scaling for the pharmacokinetics of xanthine derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.03.001

10.1016/J.YRTPH.2004.03.001

7 January 2021

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017